We are live on !
Find out more
Fifth Third Bancorp Portfolio holdings
AUM
$61.7B
Turnover
7.17%
1-Year Est. Return
33.76%
This Fund
S&P 500
This Quarter Est. Return
+19.7%
1 Year Est. Return
+33.76%
3 Year Est. Return
+104.09%
5 Year Est. Return
+123.68%
10 Year Est. Return
+382.53%
AUM
$61.7B
AUM Growth
+$6.95B
(+13%)
Cap. Flow
-$661M
Cap. Flow % of AUM
Cap. Flow %
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
29.1%
Holding
4,479
New
178
Increased
1,289
Reduced
2,227
Closed
143
Avg Time Held
Equity + Options
4.1
years
Top 10 Avg Time Held
Equity + Options
5.6
years
Top 20 Avg Time Held
Equity + Options
5.6
years
Avg Time Held Equity only
4.1
years
Top 10 Avg Time Held Equity only
5.6
years
Top 20 Avg Time Held Equity only
5.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$296M |
| 2 |
Avantis US Equity ETF
AVUS
|
+$217M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$205M |
| 4 |
BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF
XTEN
|
+$97.6M |
| 5 |
iShares Core Universal USD Bond ETF
IUSB
|
+$76.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$217M |
| 2 |
Avantis US Large Cap Value ETF
AVLV
|
+$101M |
| 3 |
Honeywell
HON
|
+$81.6M |
| 4 |
NVIDIA
NVDA
|
+$79.3M |
| 5 |
Vanguard Morningstar Mega Cap Growth ETF
MGK
|
+$77.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.79% |
| 2 | Technology | 23.11% |
| 3 | Healthcare | 9.08% |
| 4 | Financials | 8.99% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4051
Heron Therapeutics
HRTX
$57.5M
| $2.11K | ﹤0.01% |
4,934
| – | – |
2026 Q1
1 quarter
|
|
4052
Invesco S&P 500 Equal Weight Financials ETF
RSPF
$395M
| $2.08K | ﹤0.01% |
+27
| New | +$2.04K |
2026 Q2
0 quarters
|
|
4053
The RMR Group
RMR
$299M
| $2.05K | ﹤0.01% |
100
-436
| -81% | -$8.25K |
2026 Q1
1 quarter
|
|
4054
Northeast Bank
NBN
$1.11B
| $2.05K | ﹤0.01% |
15
| – | – |
2026 Q1
1 quarter
|
|
4055
Medallion Financial
MFIN
$262M
| $2.04K | ﹤0.01% |
200
| – | – |
2026 Q1
1 quarter
|
|
4056
PennyMac Mortgage Investment
PMT
$614M
| $2.04K | ﹤0.01% |
181
-230
| -56% | -$2.54K |
2022 Q1
17 quarters
|
|
4057
AdvanSix
ASIX
$424M
| $2.03K | ﹤0.01% |
102
-166
| -62% | -$3.74K |
2021 Q3
19 quarters
|
|
4058
Barings BDC
BBDC
$870M
| $2.03K | ﹤0.01% |
238
| – | – |
2026 Q1
1 quarter
|
|
4059
Inhibrx
INBX
$1.37B
| $1.99K | ﹤0.01% |
21
| – | – |
2026 Q1
1 quarter
|
|
4060
Angel Studios
ANGX
$652M
| $1.96K | ﹤0.01% |
535
| – | – |
2026 Q1
1 quarter
|
|
4061
Smith & Wesson
SWBI
$615M
| $1.94K | ﹤0.01% |
129
-40
| -24% | -$601 |
2025 Q2
4 quarters
|
|
4062
Silvaco Group
SVCO
$203M
| $1.89K | ﹤0.01% |
137
| – | – |
2026 Q1
1 quarter
|
|
4063
Telus
TU
$13.9B
| $1.88K | ﹤0.01% |
+178
| New | +$2.17K |
2026 Q2
0 quarters
|
|
4064
Benitec Biopharma
BNTC
$302M
| $1.87K | ﹤0.01% |
140
+34
| +32% | +$403 |
2026 Q1
1 quarter
|
|
4065
Prudential
PUK
$29.1B
| $1.85K | ﹤0.01% |
69
-213
| -76% | -$6.22K |
2025 Q3
3 quarters
|
|
4066
Disc Medicine
IRON
$3.31B
| $1.84K | ﹤0.01% |
25
-4
| -14% | -$275 |
2026 Q1
1 quarter
|
|
4067
Ready Capital
RC
$173M
| $1.8K | ﹤0.01% |
1,030
-81
| -7% | -$142 |
2023 Q2
12 quarters
|
|
4068
Bristol-Myers Squibb Rights
CELG.RT
$251M
| $1.8K | ﹤0.01% |
20,000
| – | – |
2020 Q2
24 quarters
|
|
4069
Nuveen Churchill Direct Lending
NCDL
$521M
| $1.8K | ﹤0.01% |
145
-800
| -85% | -$10.7K |
2026 Q1
1 quarter
|
|
4070
Uranium Energy
UEC
$3.64B
| $1.8K | ﹤0.01% |
169
+140
| +483% | +$1.88K |
2026 Q1
1 quarter
|
|
4071
Coastal Financial
CCB
$691M
| $1.8K | ﹤0.01% |
23
+6
| +35% | +$451 |
2026 Q1
1 quarter
|
|
4072
Consumer Portfolio Services
CPSS
$217M
| $1.78K | ﹤0.01% |
186
| – | – |
2026 Q1
1 quarter
|
|
4073
OP Bancorp
OPBK
$220M
| $1.78K | ﹤0.01% |
119
| – | – |
2026 Q1
1 quarter
|
|
4074
Abeona Therapeutics
ABEO
$252M
| $1.78K | ﹤0.01% |
+288
| New | +$1.58K |
2026 Q2
0 quarters
|
|
4075
Rush Enterprises Class B
RUSHB
$6.7B
| $1.76K | ﹤0.01% |
35
-16
| -31% | -$744 |
2024 Q3
7 quarters
|
|
Similar funds
Fifth Third Bancorp's Q2 2026 Portfolio in Review
As of Q2 2026, Fifth Third Bancorp held 4,479 positions worth $61.7B, up 13% from $54.7B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Fifth Third Bancorp's Q2 2026 filing shows 178 new, 1,289 increased, 2,227 reduced and 143 closed positions. Its largest new stake was Honeywell Aerospace: 342,078 shares worth $75.6M. The largest sale was Eli Lilly, an estimated $217M.
By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.
- Fifth Third Bancorp's largest Q2 2026 buy was Honeywell Aerospace: 342,078 shares worth $75.6M.
- Fifth Third Bancorp added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $296M increase.
- Fifth Third Bancorp's biggest Q2 2026 reduction was Eli Lilly, cutting an estimated $217M.
- Fifth Third Bancorp fully exited Coterra Energy in Q2 2026, selling an estimated $6.66M.
- Fifth Third Bancorp's ten largest holdings make up 29% of its $61.7B portfolio in Q2 2026.
- Fifth Third Bancorp opened 178 new positions and closed 143 in Q2 2026.
- Fifth Third Bancorp's portfolio value rose 13% quarter-over-quarter to $61.7B.
Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.